The PHV Team, along with its Strategic Alliance Partners, leverages extensive technical, programmatic, and corporate biopharma product development knowledge and capability. It comprises many of the identical individuals who effectively propelled the progress of the rVSV Zaire Ebola vaccine under two federally supported agreements. This group possesses a comprehensive comprehension of the rVSV technology platform, established proficiency in advancing other filovirus and emerging infectious disease vaccines, and overall, a verified history of successfully progressing new vaccine candidates to late-stage development and registration.
Public Health Vaccines
Headquarters
United States of America